Early Natural History of Incident, Type-specific Human Papillomavirus Infections in Newly Sexually Active Young Women
Overview
Oncology
Public Health
Authors
Affiliations
Background: Characterizing short-term detection patterns of young women's incident α-genus human papillomavirus (HPV) infections may further our understanding of HPV transmission.
Methods: Between 2000 and 2007, we followed 18- to 22-year-old female university students with triannual HPV DNA and Papanicolaou testing. Using Kaplan-Meier methods, we estimated duration of detectable, type-specific incident infections; time to redetection (among infections that became undetectable); and time to cervical lesion development after incident infection. We evaluated risk factors for short-term persistent versus transient infection with logistic regression.
Results: Three hundred three incident, type-specific infections were detected in 85 sexually active women. Median time to first negative test after incident infection was 9.4 (95% CI: 7.8-11.2) months; 90.6% of infections became undetectable within 2 years. About 19.4% of infections that became undetectable were redetected within 1 year. Cervical lesions were common and 60% were positive for multiple HPV types in concurrent cervical swabs. Incident HPV detection in the cervix only (vs. the vulva/vagina only or both sites) was associated with short-term transience.
Conclusions: Although most incident infections became undetectable within 2 years, redetection was common. Cervical lesions were a common early manifestation of HPV infection.
Impact: It remains unclear whether potentially modifiable risk factors can be identified to reduce infection duration (and transmission likelihood).
Kan X, Zhou Z, Liu L, Aiskikaer R, Zou Y Heliyon. 2025; 11(3):e42055.
PMID: 39916829 PMC: 11800076. DOI: 10.1016/j.heliyon.2025.e42055.
Sturt A, Omar T, Hansingo I, Kamfwa P, Bustinduy A, Kelly H BMC Womens Health. 2025; 25(1):2.
PMID: 39754189 PMC: 11697648. DOI: 10.1186/s12905-024-03514-0.
Wang Y, Weng J, Wu Q, Wen J, Gao Q, Lu W Infect Drug Resist. 2024; 17:5325-5334.
PMID: 39628831 PMC: 11613703. DOI: 10.2147/IDR.S484519.
Jiamsiri S, Rhee C, Ahn H, Seo H, Klinsupa W, Park S J Natl Cancer Inst Monogr. 2024; 2024(67):346-357.
PMID: 39529526 PMC: 11555278. DOI: 10.1093/jncimonographs/lgae036.
Mittal S, Kansal Y, Singh B, Gupta V Indian J Community Med. 2024; 49(4):599-603.
PMID: 39291120 PMC: 11404415. DOI: 10.4103/ijcm.ijcm_800_22.